Achieve Life Sciences, Inc.
ACHV· Nasdaq
ACHVAchieve Life Sciences, Inc.
Filed Nov 6, 2025 · 10-Q · 37 days after period end · 0001193125-25-268074
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Net Income | -$14.44M | -$12.51M | -$7.11M | -$13.08M |
| EPS Diluted | -$0.28 | -$0.36 | -$0.34 | -$1.35 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Sep 30, 2025 · filed Nov 6, 2025 · 37 d after period end
